Literature DB >> 10514481

Oncogenic Ras sensitizes cells to apoptosis by Par-4.

A Nalca1, S G Qiu, N El-Guendy, S Krishnan, V M Rangnekar.   

Abstract

Certain mutations in the mammalian ras gene are oncogenic and are often detected in human cancers. Oncogenic Ras induces the transcription activity of NF-kappaB that confers cell survival. Oncogenic Ras also down-modulates the expression of Par-4, a transcriptional repressor protein, that is essential but not sufficient on its own to induce apoptosis. Here we show that reintroduction of Par-4 by transient transfection leads to apoptosis in cells expressing oncogenic Ras but not in those that lack oncogenic Ras expression. Par-4 abrogates oncogenic Ras-inducible NF-kappaB transcription activity but does not interfere with cytoplasmic activation, or the DNA binding activity, of NF-kappaB. Because abrogation of NF-kappaB transcription activity is sufficient to cause apoptosis in cells expressing oncogenic Ras, our findings identify Par-4 as a novel example of a pro-apoptotic protein that selectively inhibits oncogenic Ras-dependent NF-kappaB function at the transcription level and suggest a mechanism by which Par-4 expression may selectively induce apoptosis in oncogenic Ras-expressing cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10514481     DOI: 10.1074/jbc.274.42.29976

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  pH-induced folding of an apoptotic coiled coil.

Authors:  K Dutta; A Alexandrov; H Huang; S M Pascal
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

Review 2.  PAR-4 as a possible new target for pancreatic cancer therapy.

Authors:  Asfar S Azmi; Philip A Philip; Syed F Zafar; Fazlul H Sarkar; Ramzi M Mohammad
Journal:  Expert Opin Ther Targets       Date:  2010-06       Impact factor: 6.902

Review 3.  Cancer-selective apoptotic effects of extracellular and intracellular Par-4.

Authors:  T Shrestha-Bhattarai; V M Rangnekar
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

4.  Par-4 binds to topoisomerase 1 and attenuates its DNA relaxation activity.

Authors:  Anindya Goswami; Shirley Qiu; Thomas S Dexheimer; Padhma Ranganathan; Ravshan Burikhanov; Yves Pommier; Vivek M Rangnekar
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

5.  Regulation of mature T lymphocyte proliferation and differentiation by Par-4.

Authors:  María José Lafuente; Pilar Martin; Isabel Garcia-Cao; María Teresa Diaz-Meco; Manuel Serrano; Jorge Moscat
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

6.  Chemoprevention of pancreatic cancer: characterization of Par-4 and its modulation by 3,3' diindolylmethane (DIM).

Authors:  Asfar Sohail Azmi; Aamir Ahmad; Sanjeev Banerjee; Vivek M Rangnekar; Ramzi M Mohammad; Fazlul H Sarkar
Journal:  Pharm Res       Date:  2008-04-22       Impact factor: 4.200

Review 7.  A journey beyond apoptosis: new enigma of controlling metastasis by pro-apoptotic Par-4.

Authors:  Reyaz Ur Rasool; Debasis Nayak; Souneek Chakraborty; Archana Katoch; Mir Mohd Faheem; Hina Amin; Anindya Goswami
Journal:  Clin Exp Metastasis       Date:  2016-08-27       Impact factor: 5.150

8.  Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network.

Authors:  Bi-Dar Wang; Christina Leah B Kline; Danielle M Pastor; Thomas L Olson; Bryan Frank; Truong Luu; Arun K Sharma; Gavin Robertson; Matthew T Weirauch; Steven R Patierno; Joshua M Stuart; Rosalyn B Irby; Norman H Lee
Journal:  Mol Cancer       Date:  2010-04-30       Impact factor: 27.401

9.  Fbxo45-mediated degradation of the tumor-suppressor Par-4 regulates cancer cell survival.

Authors:  X Chen; A A Sahasrabuddhe; P Szankasi; F Chung; V Basrur; V M Rangnekar; M Pagano; M S Lim; K S J Elenitoba-Johnson
Journal:  Cell Death Differ       Date:  2014-07-04       Impact factor: 15.828

10.  ZIP kinase triggers apoptosis from nuclear PML oncogenic domains.

Authors:  Taro Kawai; Shizuo Akira; John C Reed
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.